Special Issue "Signaling Pathway in Gastrointestinal Cancer"
Deadline for manuscript submissions: 30 April 2022.
Gastrointestinal (GI) cancers are among the most common cancers with high morbidity and mortality worldwide. In addition to traditional chemotherapy, targeted therapy and immunotherapy further improve the therapeutic efficacy and survival rate of GI cancer patients. Better understanding of the signal pathways involved in GI cancers will surely help in developing new drugs and treatment methods and improving patients’ survival. In this Special Issue, we want to present the most recent proceedings of the signal pathways involved in the development and metastasis of GI cancers. The main focus of the issue is the basic-translational oncology of GI cancer. Topics of interests include, but are not limited to, signal pathways related to tumor development, metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, and drug resistance.
This Special Issue will highlight the current state of the art in the signal pathways in GI cancers, and will cover both basic and translational aspects that advance our understanding of signal pathways in GI cancer.
Dr. Tianhui Hu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gastrointestinal cancer
- Wnt signaling
- EGFR signaling
- tumor microenvironment
- targeted therapy
- drug resistance